Lilly and ParAllele to Launch Affy-based Drug-Metabolism Genotyping Assay in August or September | GenomeWeb

NEW YORK, March 17 (GenomeWeb News) - Eli Lilly and ParAllele plan to enable contract research organizations to use their joint genotyping assay in August or September, a Lilly official told Pharmacogenomics Reporter, GenomeWeb News' sister publication, this week.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.